CSF analysis pefiatrics
CSF cerebrospinal fluid analysis pediatrics normal values interpretation
Sexually Transmitted Infections
Page 54
CSF findings meningitis encephalitis children neonates
Harrison's Principles of Internal Medicine, Twenty First Edition
Page 4156
| Parameter | Neonates (term) | Infants 1–3 mo | Children >3 mo | Adults |
|---|---|---|---|---|
| Opening pressure (cm H₂O) | 2–6 | — | 10–20 | 10–20 |
| Appearance | Clear/xanthochromic | Clear | Clear | Clear |
| WBC (cells/mm³) | ≤16–19 | ≤9–11 | ≤5 | ≤5 |
| Differential | Up to 60% PMNs possible | Mostly lymphocytes | >70% lymphocytes | >70% lymphocytes |
| Protein (mg/dL) | 65–150 (up to 170 preterm) | ≤89–91 | 15–45 | 15–45 |
| Glucose (mg/dL) | 34–119 | 40–80 | 40–80 | 40–80 |
| CSF:serum glucose ratio | ≥0.6 | ≥0.6 | ≥0.6 | ≥0.6 |
Key point: In neonates, up to 19 WBCs/mm³ and protein up to 115–118 mg/dL can be normal. These thresholds drop to 9–11 WBCs/mm³ and ≤89–91 mg/dL by 2 months (per Kestenbaum et al., Pediatrics 2010; Shah et al., J Hosp Med 2011; Thomson et al., Pediatrics 2018 — cited in STI Guidelines, p. 54).
Preterm infants have even higher normal protein levels (up to 170 mg/dL) and higher acceptable WBC counts.
| Feature | Bacterial Meningitis | Viral Meningitis/Encephalitis | TB Meningitis | Fungal Meningitis |
|---|---|---|---|---|
| Appearance | Turbid/cloudy | Clear or slightly turbid | Xanthochromic/turbid | Clear to turbid |
| WBC | 1,000–10,000+ (PMN predominant) | 10–1,000 (lymphocyte predominant) | 100–500 (lymphocyte/monocyte) | 20–500 (lymphocyte) |
| Protein | Markedly elevated (>100 mg/dL) | Normal to mildly elevated | Markedly elevated (>100 mg/dL) | Elevated |
| Glucose | Low (<40 mg/dL or CSF:serum <0.4) | Normal | Very low | Low |
| CSF:serum glucose | <0.4 | ≥0.6 | <0.3 | Low |
| Gram stain | Positive in 60–90% | Negative | Negative (AFB stain rarely+) | Negative (India ink + in Cryptococcus) |
| Cultures | Bacterial culture + | Viral PCR + | Mycobacterial culture (slow) | Fungal culture |
Viral CNS infections show lymphocytic pleocytosis with normal glucose, in contrast to the PMN pleocytosis and hypoglycorrhachia of bacterial meningitis. HSV encephalitis CSF PCR has 96% sensitivity and 99% specificity when checked 72 h after symptom onset (Harrison's, p. 4156).
| Age Group | Common Pathogens |
|---|---|
| 0–28 days | S. agalactiae (GBS), E. coli K1, Listeria monocytogenes, HSV |
| 1–3 months | GBS, E. coli, S. pneumoniae, N. meningitidis |
| 3 months – 5 years | S. pneumoniae, N. meningitidis, H. influenzae (unvaccinated) |
| >5 years | S. pneumoniae, N. meningitidis, Enteroviruses |
| Test | Indication |
|---|---|
| Cell count + differential | Baseline for all LPs |
| Glucose + simultaneous serum glucose | Distinguish bacterial vs. viral |
| Protein | Infection, GBS, demyelination |
| Gram stain + bacterial culture | Suspected bacterial meningitis |
| HSV PCR (types 1 & 2) | Neonates, encephalitis, immunocompromised |
| Enterovirus PCR | Most common viral meningitis in children |
| EBV, CMV, HHV-6 PCR | Encephalitis workup, immunocompromised |
| VDRL | Congenital syphilis (neonates) |
| Cryptococcal antigen | Immunocompromised, TB-endemic regions |
| Oligoclonal bands / IgG index | Suspected MS or demyelinating disease |
| Lactate | Bacterial vs. viral meningitis adjunct |
| Xanthochromia | Subarachnoid hemorrhage |
| Opening pressure | Pseudotumor cerebri, cryptococcal meningitis |
| Condition | Key CSF Findings |
|---|---|
| Guillain-Barré Syndrome | Albuminocytologic dissociation: elevated protein (>45 mg/dL) with normal or near-normal WBC |
| Pseudotumor cerebri | Elevated opening pressure (>25 cm H₂O); otherwise normal |
| Subarachnoid hemorrhage | Bloody in all 3 tubes; xanthochromia develops after 2–4 hours |
| Traumatic tap | Clearing of blood between tubes 1 and 3; no xanthochromia |
| TB meningitis | Fibrin web on standing; very low glucose; high protein |
| Neurosyphilis (congenital) | VDRL positive; pleocytosis; elevated protein |
| Age | Empiric Therapy |
|---|---|
| <1 month | Ampicillin + Cefotaxime (or Gentamicin) ± Acyclovir |
| 1–3 months | Ampicillin + Cefotaxime or Ceftriaxone |
| >3 months | Ceftriaxone + Vancomycin (for resistant pneumococcus) |